Learn, Analyse & Invest
only with
only with
+91
Download Orca
Wockhardt Ltd.
Wockhardt
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹246.27 Cr.
| EX-Date | Purpose |
|---|---|
| 21 04 2021 | The meeting of the Credit Facilities Committee of the Board of Directors of the Company is scheduled to be held on 21st April, 2021, inter-alia, to consider and approve the proposal for raising of funds through issuance of Non-Convertible Debentures on private placement basis. |
| 21 05 2021 | Inter alia, to consider and approve Meeting of the Credit Facilities Committee of the Board of Directors of the Company is scheduled to be held on 21st May, 2021, inter-alia, to consider and approve the proposal for raising of funds through issuance of Non-convertible Debentures on private placement basis. |
| 27 05 2021 | Audited Results Inter alia, to discuss: raising of funds by issue of Equity Shares, Global Depository Receipts, American depository receipts, Foreign Currency Convertible Bonds, fully convertible debentures, partly convertible debentures, preference shares convertible into Equity Shares, and/or any other financial instruments convertible into Equity Shares (including warrants, or otherwise, in registered or bearer form) and / or any security convertible into equity Shares, combination of any of the aforementioned securities by way of one or more public and/or private offerings, Qualified Institutions Placement and/or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law, subject to consent of shareholder at the ensuing Annual General Meeting and such approvals as may be required, and to approve ancillary actions for the above mentioned fund raising |
| 22 07 2021 | Quarterly Results |
| 08 11 2021 | Quarterly Results |
| 06 01 2022 | Inter alia, for considering and approving various fund raising options for the Company, as the Board may deem appropriate |
| 27 01 2022 | Quarterly Results |
| 03 03 2022 | Rights Issue |
| 30 05 2022 | Audited Results |
| 12 08 2022 | Quarterly Results |
| 04 11 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 26 05 2023 | Audited Results |
| 14 08 2023 | Quarterly Results |
| 14 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 26 03 2024 | Inter alia, to consider and determine the issue price of Equity Shares to be issued pursuant to the Issue, including any discount, not more than 5%, on the floor price calculated in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (?SEBI ICDR Regulations?) and approved by the shareholders of the Company pursuant to a special resolution dated 14th August, 2023. |
| 13 11 2024 | Quarterly Results |
| 07 02 2025 | Quarterly Results |
| 29 05 2025 | Audited Results |
| 08 08 2025 | Quarterly Results |
News
